Organogenesis Holdings Inc. (ORGO)

Organogenesis Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	89.35	104.34	103.29	114.53	84.81	60.37
Cash & Cash Equivalents	89.35	104.34	103.29	114.53	84.81	60.37
Cash Growth	-0.08%	1.01%	-9.81%	35.05%	40.48%	182.04%
Receivables	96.15	82	89.45	82.46	56.8	39.36
Inventory	27.69	28.25	24.78	25.02	27.8	22.92
Other Current Assets	13.98	10.45	5.09	4.97	4.94	2.95
Total Current Assets	227.17	225.04	222.61	226.98	174.34	125.6
Property, Plant & Equipment	152.86	156.35	145.66	128.3	55.79	47.18
Long-Term Investments	0	0	0	0	0	0.56
Goodwill and Intangibles	43.74	44.64	49.56	54.45	59.39	46.34
Other Long-Term Assets	34.71	33.99	31.53	33.53	0.69	1.01
Total Long-Term Assets	231.31	234.98	226.75	216.28	115.87	95.09
Total Assets	458.48	460.03	449.36	443.26	290.22	220.69
Accounts Payable	23.23	30.72	32.33	29.34	23.38	28.39
Current Debt	19.81	19.71	16.25	14.64	20.29	3.06
Other Current Liabilities	39.76	30.07	26.45	38.73	24.55	28.45
Total Current Liabilities	82.8	80.51	75.02	82.71	68.22	59.89
Long-Term Debt	96.41	99.64	107.55	117.66	64.49	97.55
Other Long-Term Liabilities	1.24	1.21	1.12	1.56	15.71	7.66
Total Long-Term Liabilities	97.65	100.85	108.67	119.22	80.19	105.21
Total Liabilities	180.45	181.36	183.69	201.92	148.41	165.1
Total Debt	116.22	119.35	123.79	132.3	84.77	100.61
Debt Growth	-5.01%	-3.59%	-6.43%	56.07%	-15.74%	69.77%
Retained Earnings	-43.07	-40.97	-45.3	-60.83	-155.04	-171.01
Shareholders' Equity	278.03	278.66	265.67	241.34	141.81	55.58
Net Cash / Debt	-26.87	-15.01	-20.5	-17.78	0.04	-40.24
Net Cash Per Share	-0.20	-0.11	-0.15	-0.13	0.00	-0.43
Working Capital	144.37	144.54	147.59	144.27	106.13	65.71
Book Value Per Share	2.11	2.12	2.04	1.88	1.32	0.60

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).